Erratum: Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro (Cellular and Molecular Life Sciences (2007) 64 (2848-2857) DOI:10.1007/s00018-007-7368-4);Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro

Cellular and Molecular Life Sciences

Volumn 64, Issue 21, 2007, Pages 2848-2857

  Lude S ^a   Torok M ^a   Dieterle, S ^a   Knapp, A C ^a   Kaeufeler, R ^b   Jaggi R ^c   Spornitz, U ^d   Krahenbuhl S ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Max Zeller Sohne AG   (Switzerland)

^c Vitaplant Ltd   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Apoptosis; Cimicifuga racemosa; Hepatotoxicity; HepG2; Mitochondria

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CIMICIFUGA RACEMOSA; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; LIVER MITOCHONDRION; LIVER TOXICITY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TOXICITY; NECROSIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT; STEATOSIS;

CIMICIFUGA; CIMICIFUGA RACEMOSA; RATTUS;

EID: 38549157627     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-010-0310-1     Document Type: Erratum

References (47)

1. Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., Kotchen, J. M. and Ockene, J. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
2. Frei-Kleiner, S., Schaffner, W., Rahlfs, V. W., Bodmer, C. and Birkhauser, M. (2005) Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 51, 397-404.
3. McKenna, D. J., Jones, K., Humphrey, S. and Hughes, K. (2001) Black cohosh: efficacy, safety, and use in clinical and preclinical applications. Altern. Ther. Health Med. 7, 93-100.
4. Nappi, R. E., Malavasi, B., Brundu, B. and Facchinetti, F. (2005) Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol. Endocrinol. 20, 30-35.
5. Uebelhack, R., Blohmer, J. U., Graubaum, H. J., Busch, R., Gruenwald, J. and Wernecke, K. D. (2006) Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet. Gynecol. 107, 247-255.
6. Pockaj, B. A., Gallagher, J. G., Loprinzi, C. L., Stella, P. J., Barton, D. L., Sloan, J. A., Lavasseur, B. I., Rao, R. M., Fitch, T. R., Rowland, K. M., Novotny, P. J., Flynn, P. J., Richelson, E. and Fauq, A. H. (2006) Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J. Clin. Oncol. 24, 2836-2841.
7. Huntley, A. and Ernst, E. (2003) A systematic review of the safety of black cohosh. Menopause 10, 58-64.
8. Dog, T. L., Powell, K. L. and Weisman, S. M. (2003) Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 10, 299-313.
9. Cohen, S. M., O'Connor, A. M., Hart, J., Merel, N. H. and Te, H. S. (2004) Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 11, 575-577.
10. Whiting, P. W., Clouston, A. and Kerlin, P. (2002) Black cohosh and other herbal remedies associated with acute hepatitis. Med. J. Aust. 177, 440-443.
11. Levitsky, J., Alli, T. A., Wisecarver, J. and Sorrell, M. F. (2005) Fulminant liver failure associated with the use of black cohosh. Dig. Dis. Sci. 50, 538-539.
12. Lontos, S., Jones, R. M., Angus, P. W. and Gow, P. J. (2003) Acute liver failure associated with the use of herbal preparations containing black cohosh. Med. J. Aust. 179, 390-391.
13. Lynch, C. R., Folkers, M. E. and Hutson, W. R. (2006) Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transpl. 12, 989-992.
14. Spornitz, U. M., Socin, C. D. and Dravid, A. A. (1999) Estrous stage determination in rats by means of scanning electron microscopic images of uterine surface epithelium. Anat. Rec. 254, 116-126.
15. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
16. Bruggisser, R., von Daeniken, K., Jundt, G., Schaffner, W. and Tullberg-Reinert, H. (2002) Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med. 68, 445-448.
17. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M. R. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107-1112.
18. Vassault, A. (1983) Lactate dehydrogenase. UV-method with pyruvate and NADH. In: Methods of Enzymatic Analysis, vol. 3. pp. 118-126, Bergmeyer, H. U. (ed.), Verlag Chemie, Weinheim.
19. Hoppel, C., DiMarco, J. P. and Tandler, B. (1979) Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J. Biol. Chem. 254, 4164-4170.
20. Gornall, A. G. (1949) Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177, 751-766.
21. Freneaux, E., Labbe, G., Letteron, P., The Le Dinh, Degott, C., Geneve, J., Larrey, D. and Pessayre, D. (1988) Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 8, 1056-1062.
22. Spaniol, M., Bracher, R., Ha, H. R., Follath, F. and Krahenbuhl, S. (2001) Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. J. Hepatol. 35, 628-636.
23. Krahenbuhl, S., Chang, M., Brass, E. P. and Hoppel, C. L. (1991) Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. J. Biol. Chem. 266, 20998-21003.
24. Kaufmann, P., Torok, M., Hanni, A., Roberts, P., Gasser, R. and Krahenbuhl, S. (2005) Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology 41, 925-935.
25. Kaufmann, P., Torok, M., Zahno, A., Waldhauser, K. M., Brecht, K. and Krahenbuhl, S. (2006) Toxicity of statins on rat skeletal muscle mitochondria. Cell. Mol. Life Sci. 63, 2415-2425.
26. Tietze, F. (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
27. Griffith, O. W. (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212.
28. Fromenty, B. and Pessayre, D. (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67, 101-154.
29. Mahler, H., Pasi, A., Kramer, J. M., Schulte, P., Scoging, A. C., Bar, W. and Krahenbuhl, S. (1997) Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N. Engl. J. Med. 336, 1142-1148.
30. Waldhauser, K. M., Torok, M., Ha, H. R., Thomet, U., Konrad, D., Brecht, K., Follath, F. and Krahenbuhl, S. (2006) Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives. J. Pharmacol. Exp. Ther. 319, 1413-1423.
31. Wolvetang, E. J., Johnson, K. L., Krauer, K., Ralph, S. J. and Linnane, A. W. (1994) Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 339, 40-44.
32. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. and Nicotera, P. (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481-1486.
33. Spaniol, M., Kaufmann, P., Beier, K., Wuthrich, J., Torok, M., Scharnagl, H., Marz, W. and Krahenbuhl, S. (2003) Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate. J. Lipid Res. 44, 144-153.
34. Fromenty, B. and Pessayre, D. (1997) Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J. Hepatol. 26 Suppl 2, 43-53.
35. Feldstein, A. E., Canbay, A., Guicciardi, M. E., Higuchi, H., Bronk, S. F. and Gores, G. J. (2003) Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 39, 978-983.
36. Sparagna, G. C., Hickson-Bick, D. L., Buja, L. M. and McMillin, J. B. (2000) Ametabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 279, H2124-H2132.
37. Wei, Y., Wang, D., Topczewski, F. and Pagliassotti, M. J. (2006) Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab. 291, E275-E281.
38. Furuno, T., Kanno, T., Arita, K., Asami, M., Utsumi, T., Doi, Y., Inoue, M. and Utsumi, K. (2001) Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. Biochem. Pharmacol. 62, 1037-1046.
39. Arora, A. S., Jones, B. J., Patel, T. C., Bronk, S. F. and Gores, G. J. (1997) Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat. Hepatology 25, 958-963.
40. Osawa, Y., Uchinami, H., Bielawski, J., Schwabe, R. F., Hannun, Y. A. and Brenner, D. A. (2005) Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. J. Biol. Chem. 280, 27879-27887.
41. Ostrander, D. B., Sparagna, G. C., Amoscato, A. A., McMillin, J. B. and Dowhan, W. (2001) Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J. Biol. Chem. 276, 38061-38067.
42. He, K., Pauli, G. F., Zheng, B., Wang, H., Bai, N., Peng, T., Roller, M. and Zheng, Q. (2006) Cimicifuga species identification by high performance liquid chromatography-photodiode array/mass spectrometric/evaporative light scattering detection for quality control of black cohosh products. J. Chromatogr. A 1112, 241-254.
43. Jiang, B., Kronenberg, F., Nuntanakorn, P., Qiu, M. H. and Kennelly, E. J. (2006) Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid chromatography-mass spectrometry. J. Agric. Food Chem. 54, 3242-3253.
44. Hostanska, K., Nisslein, T., Freudenstein, J., Reichling, J. and Saller, R. (2004) Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells. Biol. Pharm. Bull. 27, 1970-1975.
45. Hostanska, K., Nisslein, T., Freudenstein, J., Reichling, J. and Saller, R. (2004) Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res. Treat. 84, 151-160.
46. Hostanska, K., Nisslein, T., Freudenstein, J., Reichling, J. and Saller, R. (2005) Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18. Anticancer Res. 25, 139-147.
47. Johnson, B. M. and van Breemen, R. B. (2003) In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh). Chem. Res. Toxicol. 16, 838-846.